Previous studies showed that 4-hydroxy-3-methoxyindolomorphinans had variable delta opioid affinity and selectivity. Herein we show that the 3,4-dimethoxy analogs possessed similar low affinity, whereas the 3-hydroxy-4-methoxy analogs showed excellent delta opioid affinity and selectivity comparable with the parent indolomorphinans.In an attempt to improve the selectivity of the delta opioid indolomorphinans naltrindole (1) and oxymorphindole (2), 1 we previously showed that the corresponding 4-hydroxy-3-methoxyindolomorphinans (such as 3 and 4) had widely differing selectivity over mu opioid receptors, with some being very selective and others possessing poor selectivity, 2 consistent with studies by others with similarly substituted opioids. 3 The differences in affinity at delta receptors and selectivity over mu receptors compared to the indolomorphinans may be due to the presence of the 4-hydroxyl, the lack of a 3-hydroxyl, or the fact that modeling studies showed that opening the 4,5-bridge caused a shift in the relative position of the indole. 2 In addition, the 4-hydroxyl compounds proved prone to rapid oxidation and suffered from poor aqueous solubility potentially complicating the pharmacological data. Thus, for purposes of rational drug design and inclusion in our developing predictive pharmacophore model, 4 aqueous soluble analogs of 3 and 4 are required which are less prone to oxidation and only have one functional group changed from the parent indolomorphinans 1 and 2.In order to remove the problems with oxidation the 4-hydroxyl was masked as a methyl ether to give 3,4-dimethoxyindolomorphinans (6, 8) and formal 3-O-demethylation was envisioned to yield 3-hydroxy-4-methoxyindolomorphinans (7, 9) which would be directly compared to the 3-hydroxy substituted parents 1 and 2. A recent publication by Neumeyer focused on the similar class of 4-unsubstituted 3-hydroxyindolmorphinans (5) showing good affinity at delta opioid receptors, 5 prompted us to publish our findings. A similar chemical manipulation on cyprodime led to a great increase in affinity at opioid receptors, 6 lending strength to the hypothesis that 3-hydroxy-4-methoxyindolomorphinans would have high affinity, and the more exposed 3-hydroxyl was anticipated to allow greater aqueous solubility. 7The 3,4-dimethoxymorphinans were prepared as previously described utilizing reductive opening of the 4,5-bridge followed by 4-O-methylation, 7 and converted to the indolomorphinans (6, 8) (Figure 2) through standard Fisher indole condidtions. 2 We previously showed that attempted selective demethylation of the unhindered 3-methoxyl over the 4-methxoyl in the morphinans series only gave 4-demethylation with L-Selectride due to